Link Pharma Chem Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 376687, "name": "Link Pharma Chem", "stock_name": "Link Pharma Chem", "full_name": "Link Pharma Chem Ltd", "name_url": "stocks-analysis/link-pharma-chem", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "29.00", "chg": 2, "chgp": "7.41%", "dir": 1, "prev_price": "27.00", "mcapval": "12.00 Cr", "mcap": "Micro Cap", "scripcode": 524748, "symbol": "", "ind_name": "Commodity Chemicals", "ind_code": 11, "indexname": "", "isin": "INE302F01011", "curr_date": "Mar 05", "curr_time": "", "bse_nse_vol": "1.01 k", "exc_status": "Active", "traded_date": "Mar 05, 2026", "traded_date_str": "2026 03 05", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/link-pharma-chem-376687-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Link Pharma Chem Ltd Downgraded to Strong Sell Amid Mixed Financials and Valuation Shifts", "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-downgraded-to-strong-sell-amid-mixed-financials-and-valuation-shifts-3872824", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_mojoScore_3872824.png", "date": "2026-03-05 08:15:54", "description": "Link Pharma Chem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 4 March 2026, reflecting a complex interplay of valuation improvements, deteriorating financial trends, and weak quality metrics. Despite an attractive valuation profile, the company’s long-term fundamentals and technical indicators have raised concerns among analysts, prompting a reassessment of its investment appeal within the commodity chemicals sector." }, { "title": "Link Pharma Chem Ltd Valuation Shifts Amidst Challenging Market Conditions", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-amidst-challenging-market-conditions-3872463", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_valuationdot_3872463.png", "date": "2026-03-05 08:00:33", "description": "Link Pharma Chem Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing challenges in profitability and market performance. This recalibration in price attractiveness comes amid a backdrop of subdued returns relative to the broader Sensex and a deteriorating financial quality profile, prompting a reassessment of its investment appeal within the commodity chemicals sector." }, { "title": "Link Pharma Chem Ltd Falls to 52-Week Low of Rs.23.5 Amidst Continued Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-falls-to-52-week-low-of-rs235-amidst-continued-underperformance-3864438", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_priceRelatedfactors_3864438.png", "date": "2026-03-02 10:56:28", "description": "Link Pharma Chem Ltd’s stock touched a fresh 52-week low of Rs.23.5 today, marking a significant decline amid ongoing challenges in the commodity chemicals sector. The stock’s performance continues to lag behind key benchmarks, reflecting persistent pressures on the company’s financial metrics and market positioning." }, { "title": "Link Pharma Chem Ltd Valuation Shifts to Attractive Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-attractive-amid-mixed-market-returns-3851933", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LinkPharmaChemL_valuationdot_3851933.png", "date": "2026-02-24 08:00:39", "description": "Link Pharma Chem Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite ongoing operational challenges. This article analyses the company’s current valuation metrics in comparison with its historical averages and peer group, providing investors with a comprehensive view of its market positioning as of February 2026." }, { "title": "Link Pharma Chem Ltd Falls 3.20%: 2 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-falls-320-2-key-factors-driving-the-weekly-decline-3850000", "imagepath": "", "date": "2026-02-21 17:10:29", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Stock opens at Rs.29.95, marginally down</p>\n <p><strong>17 Feb:</strong> Positive Q4 2025 financial turnaround announced</p>\n <p><strong>17 Feb:</strong> Valuation shifts to very attractive amid mixed market performance</p>\n <p><strong>18 Feb:</strong> Sharp decline of 3.83% on heavy volume</p>\n <p><strong>19 Feb:</strong> Recovery rally of 3.28% despite Sensex fall</p>\n <p><strong>20 Feb:</strong> Week closes at Rs.29.03, down 1.93% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat..." }, { "title": "Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amid Mixed Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-very-attractive-amid-mixed-market-performance-3843259", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LinkPharmaChemL_valuationdot_3843259.png", "date": "2026-02-17 08:01:40", "description": "Link Pharma Chem Ltd, a player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a challenging market backdrop and mixed returns relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling investment case for value-focused investors." }, { "title": "Link Pharma Chem Ltd Reports Positive Financial Turnaround in Q4 2025", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-reports-positive-financial-turnaround-in-q4-2025-3843088", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LinkPharmaChemL_fintrenddot_3843088.png", "date": "2026-02-17 08:00:12", "description": "Link Pharma Chem Ltd, a player in the commodity chemicals sector, has demonstrated a notable improvement in its financial performance for the quarter ended December 2025. The company’s financial trend has shifted from flat to positive, reflecting growth in net sales, profitability, and operating margins, despite persistent challenges in receivables management and a subdued stock performance relative to broader market indices." }, { "title": "Are Link Pharma Chem Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-link-pharma-chem-ltd-latest-results-good-or-bad-3840439", "imagepath": "", "date": "2026-02-14 19:48:18", "description": "Link Pharma Chem Ltd's latest financial results for Q2 FY26 present a challenging operational landscape. The company reported net sales of ₹6.29 crores, reflecting a quarter-on-quarter decline of 19.46% from ₹7.81 crores in Q1 FY26, although there was a year-on-year growth of 31.04% compared to ₹4.80 crores in Q2 FY25. This year-on-year growth, however, is somewhat misleading as it comes from a particularly weak base in the prior year.\n\nThe most concerning aspect of the results is the significant drop in profitability. The net profit after tax for Q2 FY26 was just ₹0.02 crores, a staggering 95% decrease from ₹0.40 crores in the previous quarter. The profit after tax margin fell to a mere 0.32%, indicating severe operational stress. Operating margins also contracted sharply to 5.41% from 8.19% in Q1 FY26, suggesting challenges in cost management and pricing power.\n\nDespite a notable revenue growth year-on-ye..." }, { "title": "Link Pharma Chem Ltd Falls to 52-Week Low of Rs.28 Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-falls-to-52-week-low-of-rs28-amidst-continued-downtrend-3787337", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LinkPharmaChemL_priceRelatedfactors_3787337.png", "date": "2026-01-09 15:40:42", "description": "Link Pharma Chem Ltd has touched a fresh 52-week low of Rs.28 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial performance and valuation metrics." } ], "total": 89, "sid": "376687", "stock_news_url": "https://www.marketsmojo.com/news/link-pharma-chem-376687" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Feb-2026", "details": "Newspaper advertisement of unaudited financial results for the quarter and Nine months ended December 31 2025", "source": "BSE" }, { "caption": "We Herewith Submit Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December 2025", "datetime": "14-Feb-2026", "details": "We herewith submit unaudited financial result for the quarter and nine months ended on 31st December 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for We Herewith Submit Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December 2025", "datetime": "14-Feb-2026", "details": "We herewith submit unaudited financial result for the quarter and Nine months ended on 31st December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Feb: Stock opens at Rs.29.95, marginally down

17 Feb: Positive Q4 2025 financial turnaround announced

17 Feb: Valuation shifts to very attractive amid mixed market performance

18 Feb: Sharp decline of 3.83% on heavy volume

19 Feb: Recovery rally of 3.28% despite Sensex fall

20 Feb: Week closes at Rs.29.03, down 1.93% on the day

Read full news article

Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amid Mixed Market Performance

2026-02-17 08:01:40

Link Pharma Chem Ltd, a player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a challenging market backdrop and mixed returns relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling investment case for value-focused investors.

Read full news article

Link Pharma Chem Ltd Reports Positive Financial Turnaround in Q4 2025

2026-02-17 08:00:12

Link Pharma Chem Ltd, a player in the commodity chemicals sector, has demonstrated a notable improvement in its financial performance for the quarter ended December 2025. The company’s financial trend has shifted from flat to positive, reflecting growth in net sales, profitability, and operating margins, despite persistent challenges in receivables management and a subdued stock performance relative to broader market indices.

Read full news article

Are Link Pharma Chem Ltd latest results good or bad?

2026-02-14 19:48:18

Link Pharma Chem Ltd's latest financial results for Q2 FY26 present a challenging operational landscape. The company reported net sales of ₹6.29 crores, reflecting a quarter-on-quarter decline of 19.46% from ₹7.81 crores in Q1 FY26, although there was a year-on-year growth of 31.04% compared to ₹4.80 crores in Q2 FY25. This year-on-year growth, however, is somewhat misleading as it comes from a particularly weak base in the prior year. The most concerning aspect of the results is the significant drop in profitability. The net profit after tax for Q2 FY26 was just ₹0.02 crores, a staggering 95% decrease from ₹0.40 crores in the previous quarter. The profit after tax margin fell to a mere 0.32%, indicating severe operational stress. Operating margins also contracted sharply to 5.41% from 8.19% in Q1 FY26, suggesting challenges in cost management and pricing power. Despite a notable revenue growth year-on-ye...

Read full news article

Link Pharma Chem Ltd Falls to 52-Week Low of Rs.28 Amidst Continued Downtrend

2026-01-09 15:40:42

Link Pharma Chem Ltd has touched a fresh 52-week low of Rs.28 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial performance and valuation metrics.

Read full news article